Biosimilar market growth is mainly driven by the rising incidences of chronic diseases and increasing demand for their cost-effectiveness.
The global market for biosimilar will most likely expand at over 11.5% CAGR between 2023 to 2032.
The biosimilar market size was estimated to be US$ 29.5 billion in 2021
Apotex Inc., Biocad, mAbxience, Fujifilm Kyowa Kirin Biologics Co Ltd. and Intas Pharmaceuticals Ltd. are the top 5 biosimilar manufacturers.
The biosimilar analysis market has been assessed for the years 2019 to 2032.
Based on indications, the biosimilar market is segmented into Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases and Other Indications.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved